Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
In Group C, the preponderant reason was represented by the discomfort for the repeated nasal reactions, which explains the very early interruption of immunotherapy in 43.9% of the patients belonging to this group. [...]the nasal route of administration, even though scientifically demonstrated as effective, does not represent in practice an advisable option for immunotherapy.